** Medical device maker Enovis Corp ENOV.N down 4% at $35.76
** ENOV reiterates Q1 revenue forecast to be in the range of $555 million to $563 million vs analysts' estimate of $559.6 million, according to data compiled by LSEG
** Brokerage Evercore ISI analyst Vijay Kumar says shares are down partly because co reiterated Q1 forecast but did not mention forecast for the year
** Separately, ENOV appoints Damien McDonald as chief executive officer effective May 12, 2025
** CEO Matt Trerotola previously said in February his intention to retire
** Co says Trerotola will not stand for re-election
** Stock has fallen 18.6% YTD
(Reporting by Siddhi Mahatole)
((siddhi.mahatole@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。